This image is not available for purchase in your country.

Meprobamate anti-anxiety drug

Meprobamate anti-anxiety drug

C014/2275

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

B. BOISSONNET / BSIP / SCIENCE PHOTO LIBRARY B. BOISSONNET / BSIP / SCIENCE PHOTO LIBRARY

Restrictions:

Editorial Only.

Caption

Meprobamate. Packet of the anti-anxiety drug meprobamate (marketed as Equanil). This drug was withdrawn from the European market in 2012 due to its addictive properties, low overdose threshold and severe withdrawal symptoms, which can include coma and death.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}